ABBOTT PARK, Illinois, USA--Abbott (NYSE: ABT), has secured CE Mark for the Abbott’s Libre Duo system, which combines continuous tracking for both glucose and ketones into a single wearable sensor,the world's first dual glucose-ketone sensing technology for people with diabetes, according to the WORLD RECORD ACADEMY.